Endo Reports First-Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Endo Int'l (ENDP) Tops Q1 EPS by 13c; Reaffirms
May 9, 2017 6:31 AM EDTEndo Int'l (NASDAQ: ENDP) reported Q1 EPS of $1.23, $0.13 better than the analyst estimate of $1.10. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.02 billion.
First-quarter 2017 revenues increased 8 percent from prior year to $1,038 millionFirst-quarter 2017 U.S. Generic Pharmaceuticals revenue increased 24 percent to... More